Abstract
Effective therapies for Ig light chain (AL) amyloidosis has led to an increasing proportion of patients with end-stage renal disease requiring renal replacement therapy, yet kidney transplantation is seldom performed in this setting due to concerns of renal and extrarenal disease progression. Angel-Korman et al. report unprecedented positive long-term outcomes in the largest series of kidney transplantation in AL amyloidosis providing the basis for a more proactive approach to this procedure.
Original language | English |
---|---|
Pages (from-to) | 258-260 |
Number of pages | 3 |
Journal | Kidney International |
Volume | 95 |
Issue number | 2 |
DOIs |
|
Publication status | Published - Feb 1 2019 |
ASJC Scopus subject areas
- Nephrology